Adaptimmune Therapeutics plc ADR (473A)
Market Open
14 Aug, 06:01
€
0. 02
0
0%
€
- Market Cap
- P/E Ratio
- Div Yield
4,300 Volume
-0.44 Eps
€ 0.02
Previous Close Want to track 473A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Adaptimmune Therapeutics plc ADR (473A) Statistics
Valuation metrics
Market Cap -
Enterprise value -16.93M
Trailing P/E (ttm) -0.05
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) -0.06
Enterprise Value/Revenue -0.1
Enterprise Value/EBITDA 0.47
Overview
Shares outstanding 1.59B
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 430
Average volume (90 days) 143
Price summary
52-Week low 0
52-Week high 0.23
Beta -
50-Day moving average 0.01
200-Day moving average 0.04
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 1%
Operating margin -0.36%
Operational effectiveness
Return on assets -0.29%
Return on equity -5.98%
Income Statement
Revenue (ttm) 178.03M
Revenue per share (ttm) 0.71
Quarterly revenue growth (yoy) 0.88%
Gross profit (ttm) 177.96M
EBITDA -
Net income to common (ttm) -70.81M
Diluted EPS (ttm) -0.3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 48.68M
Total Debt/Equity (mrq) -0.69
Current ratio (mrq) 1.52%
Book value per share (mrq) -0.27
Cash Flow
Cash flow statement -93.95M
Levered free cash flow (LFCF) -70.81M
